D82.4
Hyperimmunoglobulin E [IgE] syndrome
Clinical Classification Guidelines
Medical Intelligence & Overview
Hyperimmunoglobulin E (IgE) syndrome, also known as Job syndrome, is a rare immune disorder characterized by an excessive production of immunoglobulin E (IgE) antibodies. This condition affects the immune system's ability to combat infections effectively, leading to frequent health issues. People with this syndrome often experience unique skin and lung problems alongside recurrent infections, which can significantly impact daily life.
Causes & Symptoms
Clinical Causes: Genetic mutations: The condition is primarily caused by genetic mutations affecting the immune system's development, often inherited in an autosomal dominant pattern. Defects in immune cell function: These mutations lead to abnormalities in immune cells such as T-helper cells, which play a crucial role in fighting infections. Disrupted cytokine signaling: The problem involves impaired cytokine signaling pathways, which are vital for immune regulation and defense mechanisms.
Key Symptoms: Recurrent skin infections, often presenting as abscesses and suppurative skin lesions. Frequent respiratory infections, including pneumonia, sinusitis, and bronchitis. Eczema or dermatitis, resulting in inflamed, itchy skin. High levels of IgE antibodies in the blood, often many times higher than normal. Characteristic facial features, such as a broad nose, deep-set eyes, and prominent forehead. Development of cysts and abscesses in various tissues. Increased susceptibility to certain fungal and bacterial infections. Delayed shedding of primary teeth and other dental abnormalities. Potential for skeletal anomalies such as scoliosis or joint hyperextensibility.
Diagnostic & Treatment
Diagnosis Path: Diagnosing hyperimmunoglobulin E syndrome involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Key steps include: - Blood tests to measure immunoglobulin E levels, which are typically elevated. - Complete blood count (CBC) to assess other immune cell components. - Skin or blood tests to identify specific allergies. - Imaging studies to evaluate structural abnormalities. - Genetic testing to detect mutations associated with the syndrome, primarily in the STAT3 gene. - Detailed medical history focusing on infection patterns and developmental milestones. Early diagnosis is important to manage symptoms effectively and prevent complications.
Treatment Protocols: There is no cure for hyperimmunoglobulin E syndrome, but various treatments can help manage symptoms and reduce the risk of infections. Approaches include: - Antibiotics and antifungal medications to treat and prevent recurrent infections. - Regular skin care routines to manage eczema and prevent skin infections. - Immunomodulatory therapies, such as intravenous immunoglobulin (IVIG), in some cases. - Stem cell transplantation may be considered in severe cases, although this is less common. - Monitoring for and addressing skeletal or dental abnormalities. - Supportive therapies, including physical therapy or surgical interventions, as needed. - Regular check-ups with healthcare providers for early intervention upon new symptoms or infections. Effective management often involves a multidisciplinary team including immunologists, dermatologists, dentists, and other specialists.
Clinical Advice & FAQs
Billing Guidance
Is D82.4 a billable ICD-10 code?
Yes, D82.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D82.4?
Clinical documentation must specify the nature of Hyperimmunoglobulin E [IgE] syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
